Literature DB >> 2829622

Inapparent infection of hepatitis A virus.

N Y Yang1, P H Yu, Z X Mao, N L Chen, S A Chai, J S Mao.   

Abstract

To detect inapparent infection with hepatitis A virus, serial sera were collected from patients with hepatitis A and their contacts in two waterborne epidemics in China. Epidemic 1 occurred in a rural village near Hangzhou during August 1978-January 1979, and epidemic 2 took place in a rural primary school in Pinghu County in Zhejiang in April-May 1985. These sera were tested for antibodies against hepatitis A virus (anti-HAV), serum glutamic pyruvic transaminase (SGPT) activity, and icteric index. Feces also were collected in epidemic 1 to test for hepatitis A virus antigen. Both anti-HAV immunoglobulin M (IgM) and total anti-HAV were assayed in sera from "healthy persons" (symptomless persons without icterus and with normal SGPT level) who were in close contact with hepatitis A patients. In epidemic 1, among 18 "healthy persons", 12 were anti-HAV IgM positive, two were immune, and four susceptibles escaped infection. In epidemic 2, among 32 "healthy children", three were anti-HAV IgM positive, five had been infected by hepatitis A virus in the past, and 24 were not infected. These results demonstrate that inapparent infections occur along with overt and subclinical infections during epidemics of hepatitis A. The proportions of inapparent, subclinical, and overt infections were, respectively, 34.3%, 45.7%, and 20% in epidemic 1, and 25%, 50%, and 25% in epidemic 2. In addition, hepatitis A virus particles were demonstrated in the feces of all infected subjects who were examined and who included all levels of clinical response. These particles were identified with immuno-electron microscopy and enzyme-linked immunoassay.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2829622

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

Review 1.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 2.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 3.  Liver disease.

Authors:  S D Ryder; R Williams
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

4.  Diagnostic relevance of immunoglobulin G avidity for hepatitis A virus.

Authors:  Anne-Marie Roque-Afonso; Liliane Grangeot-Keros; Bénédicte Roquebert; Delphine Desbois; Jean-Dominique Poveda; Vincent Mackiewicz; Elisabeth Dussaix
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  Evaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM.

Authors:  Hyeok-Jin Lee; Hye Sook Jeong; Byung-Ki Cho; Mi-Jeong Ji; Ji-Ha Kim; An-Na Lee; Kyoung-Ryul Lee; Doo-Sung Cheon
Journal:  Virol J       Date:  2010-07-19       Impact factor: 4.099

6.  Whole genome sequencing to identify host genetic risk factors for severe outcomes of hepatitis a virus infection.

Authors:  Dustin Long; Oren K Fix; Xutao Deng; Mark Seielstad; Adam S Lauring
Journal:  J Med Virol       Date:  2014-06-30       Impact factor: 2.327

7.  Seroprevalence of IgM antibodies to hepatitis A virus in at-risk group in Benin City, Nigeria.

Authors:  Helen O Ogefere; Christopher A Egbe
Journal:  Libyan J Med       Date:  2016-04-21       Impact factor: 1.657

8.  Epidemiological investigation of an outbreak of hepatitis A at a residential facility for the disabled, 2011.

Authors:  Hyun-Sul Lim; Kumbal Choi; Saerom Lee
Journal:  J Prev Med Public Health       Date:  2013-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.